Pharmacokinetics and Pharmacodynamics — MCQs

Pharmacokinetics and Pharmacodynamics Indian Medical PG Practice Questions and MCQs

Question 151: Which NSAID undergoes enterohepatic circulation?

A. Phenylbutazone
B. Aspirin
C. Ibuprofen
D. Piroxicam (Correct Answer)

Explanation: **Explanation:** **Piroxicam** is a long-acting oxicam derivative. The primary reason for its prolonged half-life (approximately 50 hours) is its extensive **enterohepatic circulation**. After being absorbed and metabolized in the liver, a significant portion of the drug is excreted into the bile and subsequently reabsorbed from the gastrointestinal tract back into the systemic circulation. This recycling mechanism allows the drug to maintain therapeutic plasma concentrations for a longer duration, enabling convenient **once-daily dosing**. **Analysis of Incorrect Options:** * **Phenylbutazone:** While it has a long half-life (50–100 hours), this is primarily due to its slow metabolism and high plasma protein binding, rather than significant enterohepatic recycling. * **Aspirin:** It is a short-acting NSAID that is rapidly hydrolyzed to salicylic acid. It follows first-order kinetics at low doses and zero-order kinetics at high doses, but does not undergo enterohepatic circulation. * **Ibuprofen:** A propionic acid derivative with a short half-life (approx. 2 hours). It is rapidly metabolized and excreted in the urine, requiring multiple daily doses. **High-Yield Clinical Pearls for NEET-PG:** * **Indomethacin** is another classic example of an NSAID that undergoes significant enterohepatic circulation (often associated with GI side effects). * **Piroxicam** is associated with a higher risk of gastric ulcers and bleeding compared to other NSAIDs due to its long duration of action. * **Clinical Tip:** Drugs undergoing enterohepatic circulation often show a "second peak" in plasma concentration curves and are more susceptible to interactions with broad-spectrum antibiotics (which disrupt gut flora required for deconjugation).

Question 152: What is the bioavailability?

A. Area under the plasma concentration-time curve (AUC) of oral administration / AUC of intravenous administration
B. AUC of intravenous administration / AUC of oral administration
C. (AUC of oral administration / AUC of intravenous administration) * 100 (Correct Answer)
D. (AUC of intravenous administration / AUC of oral administration) * 100

Explanation: **Explanation:** **Bioavailability (F)** is defined as the fraction of an administered dose of unchanged drug that reaches the systemic circulation. It is a key pharmacokinetic parameter used to determine the efficiency of drug absorption. **Why Option C is Correct:** To calculate absolute bioavailability, we compare the systemic exposure of a drug after extravascular (e.g., oral) administration to its exposure after intravenous (IV) administration. Since IV administration bypasses absorption barriers and first-pass metabolism, its bioavailability is considered 100% (F=1). The **Area Under the Curve (AUC)** represents the total drug exposure over time. Therefore, the formula is: $$F = \frac{AUC_{\text{oral}}}{AUC_{\text{IV}}} \times 100$$ This ratio expresses what percentage of the oral dose actually reached the bloodstream compared to the "gold standard" IV route. **Why Other Options are Incorrect:** * **Option A:** This represents the fraction (F) in decimal form. While mathematically similar, bioavailability is conventionally expressed as a **percentage** in clinical pharmacology contexts. * **Options B & D:** These are mathematically inverted. Since the AUC of an oral dose is almost always less than or equal to the IV dose (due to incomplete absorption or first-pass metabolism), placing the IV AUC in the numerator would result in a value >100%, which is physiologically impossible. **NEET-PG High-Yield Pearls:** * **IV Route:** Bioavailability is always **100% (F=1)**. * **First-Pass Metabolism:** Drugs with high first-pass metabolism (e.g., Nitroglycerin, Propranolol, Lidocaine) have low oral bioavailability. * **Bioequivalence:** Two formulations of the same drug are bioequivalent if their rate and extent of absorption (AUC and $C_{max}$) do not show a significant statistical difference. * **Factors affecting F:** Gastric pH, presence of food, drug solubility, and intestinal transporters (P-glycoprotein).

Question 153: Which of the following drugs is not administered by the intradermal route?

A. BCG
B. Insulin (Correct Answer)
C. Mantoux
D. Drug sensitivity injection

Explanation: **Explanation:** The **intradermal (ID) route** involves injecting a small volume of medication into the dermis, just below the epidermis. This route is primarily used for diagnostic purposes, sensitivity testing, and specific vaccinations because the dermis has a limited blood supply, leading to slow systemic absorption. **Why Insulin is the Correct Answer:** Insulin is traditionally administered via the **subcutaneous (SC) route**. The subcutaneous tissue (fatty layer) allows for a consistent, slow, and predictable absorption rate into the systemic circulation. Injecting insulin intradermally would result in erratic absorption and significant pain, making it clinically inappropriate for routine glucose management. **Analysis of Incorrect Options:** * **BCG (Bacillus Calmette-Guérin):** This is the classic example of an ID injection. It must be given intradermally to induce a local delayed-type hypersensitivity reaction; accidental subcutaneous injection can lead to abscess formation. * **Mantoux Test:** Used for tuberculosis screening (Tuberculin Skin Test), PPD is injected intradermally to observe for induration, which indicates a T-cell mediated immune response. * **Drug Sensitivity Injection:** Skin prick or ID tests (e.g., for Penicillin) are used to detect immediate IgE-mediated hypersensitivity (Type I) before administering a full dose. **High-Yield Clinical Pearls for NEET-PG:** * **Angle of Injection:** ID injections are given at a **10–15 degree angle**, while SC injections are typically given at **45–90 degrees**. * **Volume:** ID route accommodates very small volumes (usually **0.1 ml**). * **Rabies Vaccine:** The **Thai Red Cross regimen** (ID) is a cost-effective alternative to the intramuscular route, utilizing the high density of antigen-presenting cells (Langerhans cells) in the skin. * **Other ID Vaccines:** Smallpox vaccine (multiple puncture) and some newer Influenza vaccines.

Question 154: Epinephrine acts by stimulating which of the following?

A. Adenyl cyclase (Correct Answer)
B. Phosphodiesterase
C. Phospholipase
D. None of the above

Explanation: **Explanation:** Epinephrine (Adrenaline) is a potent catecholamine that acts as a non-selective agonist at alpha ($\alpha$) and beta ($\beta$) adrenergic receptors. The correct answer is **Adenyl cyclase** because the primary mechanism for epinephrine’s most significant physiological effects (especially via $\beta$-receptors) involves the **G-protein coupled receptor (GPCR)** pathway. 1. **Why Adenyl Cyclase is correct:** When epinephrine binds to $\beta_1, \beta_2,$ or $\beta_3$ receptors, it activates a stimulatory G-protein ($G_s$). This $G_s$ protein activates the enzyme **Adenyl cyclase**, which converts ATP into **cyclic AMP (cAMP)**. cAMP then acts as a second messenger to activate Protein Kinase A (PKA), leading to effects like increased heart rate (positive inotropy/chronotropy) and bronchodilation. 2. **Why Phosphodiesterase is incorrect:** Phosphodiesterase (PDE) is the enzyme responsible for the *breakdown* of cAMP into 5'-AMP. Epinephrine increases cAMP levels; it does not stimulate the enzyme that destroys it. (Note: PDE inhibitors like Theophylline or Milrinone are used to keep cAMP levels high). 3. **Why Phospholipase is incorrect:** Phospholipase C is typically associated with $G_q$-coupled receptors (like $\alpha_1$). While epinephrine does act on $\alpha_1$ receptors, its classic systemic "fight or flight" profile is dominated by the Adenyl cyclase-cAMP pathway. **High-Yield Clinical Pearls for NEET-PG:** * **Receptor Potency:** At low doses, epinephrine has a higher affinity for $\beta_2$ receptors (vasodilation); at high doses, $\alpha_1$ effects predominate (vasoconstriction). * **Drug of Choice:** Epinephrine (1:1000 IM) is the drug of choice for **Anaphylactic Shock**. * **Glucagon connection:** Like epinephrine, Glucagon also acts via Adenyl cyclase, which is why it is used as an antidote for Beta-blocker poisoning.

Question 155: Which of the following is NOT a characteristic of active drug transport?

A. Energy dependent
B. Makes use of specific transporter proteins
C. Carrier transport is nonsaturable (Correct Answer)
D. Carries the drug against the concentration gradient

Explanation: ### Explanation **1. Why Option C is the Correct Answer (The Concept of Saturation)** Active transport relies on specific **carrier proteins** (transporters) located in the cell membrane [1]. These carriers have a finite number of binding sites. When all available binding sites are occupied by drug molecules, the transport system reaches its maximum capacity ($V_{max}$). This phenomenon is known as **saturation**. Therefore, saying active transport is "nonsaturable" is incorrect; it follows **Michaelis-Menten kinetics** (zero-order kinetics at high concentrations). In contrast, passive diffusion is nonsaturable because it does not require a mediator. **2. Analysis of Incorrect Options** * **Option A (Energy dependent):** Active transport requires the hydrolysis of ATP (Primary active transport) or utilizes the electrochemical gradient of another solute (Secondary active transport) to move drugs [1]. * **Option B (Specific transporter proteins):** Unlike passive diffusion, active transport is highly selective [3]. It requires specific transmembrane proteins (e.g., P-glycoprotein, OATP) that recognize specific molecular structures. * **Option D (Against concentration gradient):** This is the hallmark of active transport [2]. It moves drugs from an area of lower concentration to an area of higher concentration ("uphill" transport), unlike facilitated diffusion or passive diffusion [3]. **3. NEET-PG High-Yield Clinical Pearls** * **Competition:** Since carriers are specific, two drugs competing for the same transporter can lead to **drug-drug interactions** (e.g., Probenecid inhibits the active tubular secretion of Penicillin, prolonging its action). * **P-glycoprotein (P-gp):** An important efflux active transporter [3]. It pumps drugs out of cells (e.g., in the blood-brain barrier or cancer cells), often contributing to **multi-drug resistance** [4]. * **Facilitated Diffusion vs. Active Transport:** Both are saturable and carrier-mediated, but facilitated diffusion does **not** require energy and cannot move drugs against a gradient [3].

Question 156: In which body compartment is a plasma protein-bound drug primarily distributed?

A. Extracellular fluid
B. Intravascular fluid (Correct Answer)
C. Interstitial fluid
D. Extravascular fluid

Explanation: ### Explanation **1. Why Intravascular Fluid is Correct:** The distribution of a drug depends heavily on its molecular size and binding characteristics. When a drug is highly bound to **plasma proteins** (like albumin or $\alpha_1$-acid glycoprotein), the resulting drug-protein complex becomes too large to permeate through the capillary endothelium. Consequently, the drug remains trapped within the circulatory system, specifically in the **intravascular compartment** (plasma). These drugs typically have a **low Volume of Distribution ($V_d$)**, approximately 3–4 Liters in a 70kg adult. **2. Why Other Options are Incorrect:** * **Extracellular Fluid (ECF):** This includes both plasma and interstitial fluid. While water-soluble drugs (low molecular weight) can distribute here, protein-bound drugs are restricted from crossing into the interstitium. * **Interstitial Fluid:** This is the fluid surrounding cells outside the blood vessels. Protein-bound drugs cannot easily enter this space because the capillary basement membrane acts as a barrier to large protein complexes. * **Extravascular Fluid:** This refers to all fluid outside the blood vessels (interstitial + intracellular). Protein-bound drugs, by definition, are sequestered within the vasculature and do not reach extravascular sites in significant concentrations. **3. NEET-PG High-Yield Pearls:** * **Volume of Distribution ($V_d$):** Drugs restricted to the intravascular compartment (e.g., **Warfarin, Heparin, Insulin**) have the lowest $V_d$. * **Albumin vs. Acid Glycoprotein:** Acidic drugs (e.g., NSAIDs, Phenytoin) bind to **Albumin**, while basic drugs (e.g., Lidocaine, Propranolol) bind to **$\alpha_1$-acid glycoprotein**. * **Clinical Significance:** Only the **"free" (unbound) fraction** of a drug is pharmacologically active, metabolized, and excreted. In conditions like hypoalbuminemia, the free fraction of drugs like Phenytoin increases, potentially leading to toxicity even if total plasma levels appear normal.

Question 157: Which of the following is a pro-drug?

A. Cyclophosphamide (Correct Answer)
B. Lisinopril
C. Metochlopramide
D. Ranitidine

Explanation: **Explanation:** **Cyclophosphamide** is the correct answer because it is a classic example of a **pro-drug**. A pro-drug is a pharmacologically inactive compound that must undergo metabolic conversion (biotransformation) within the body to become an active metabolite. Cyclophosphamide, an alkylating agent used in chemotherapy, is inactive in its parent form. It requires activation by **hepatic cytochrome P450 enzymes** (specifically CYP2B6) to form 4-hydroxycyclophosphamide and aldophosphamide, which eventually break down into the active cytotoxic moiety, **phosphoramide mustard**. **Analysis of Incorrect Options:** * **Lisinopril:** This is a high-yield exception among ACE inhibitors. While most ACE inhibitors (like Enalapril or Ramipril) are pro-drugs, **Lisinopril and Captopril** are active in their parent form and do not require hepatic activation. * **Metoclopramide:** This is a prokinetic and antiemetic agent that is active upon administration. It acts directly as a $D_2$ receptor antagonist. * **Ranitidine:** This is an $H_2$ receptor antagonist used to reduce gastric acid secretion. It is an active drug and does not require metabolic activation to exert its effect. **NEET-PG Clinical Pearls:** * **Acrolein:** The activation of Cyclophosphamide also produces acrolein, a toxic metabolite responsible for **hemorrhagic cystitis**. This is prevented by administering **MESNA** (2-Mercaptoethane sulfonate) and aggressive hydration. * **Pro-drug Exceptions:** Remember that most ACE inhibitors are pro-drugs *except* Lisinopril and Captopril. * **Common Pro-drugs to remember:** Levodopa (to Dopamine), Enalapril (to Enalaprilat), Clopidogrel, Terfenadine (to Fexofenadine), and Prednisone (to Prednisolone).

Question 158: What is a prodrug?

A. The prototype member of a class of drugs.
B. The oldest member of a class of drugs.
C. An inactive drug that is transformed in the body to an active metabolite. (Correct Answer)
D. A drug that is stored in body tissues and is then gradually released.

Explanation: A **prodrug** is a pharmacologically inactive compound that must undergo chemical or enzymatic biotransformation (usually in the liver or gut wall) to be converted into its active, therapeutic form. This strategy is often used to improve a drug's bioavailability, reduce toxicity, or enhance site-specific delivery. ### Why Option C is Correct: The defining characteristic of a prodrug is its **initial lack of activity**. Once ingested, metabolic processes (like hydrolysis or oxidation) "unmask" the active moiety. For example, **Enalapril** is an inactive prodrug that is converted by hepatic esterases into **Enalaprilat**, which then inhibits the ACE enzyme. ### Why Other Options are Incorrect: * **Option A & B:** These refer to the "Lead Compound" or the first drug discovered in a category (e.g., Morphine for opioids). While they are historical benchmarks, they are often active in their original form. * **Option D:** This describes the process of **redistribution** or tissue storage (e.g., Thiopentone storing in adipose tissue), which relates to the duration of action rather than metabolic activation. ### NEET-PG High-Yield Pearls: * **Common Prodrugs (Mnemonic: "All Prefer Doing MD"):** **A**CE inhibitors (except Captopril and Lisinopril), **P**roton Pump Inhibitors (Omeprazole), **D**opamine precursors (Levodopa), **M**ethyldopa, **D**ipivefrine. * **Exceptions:** **Captopril** and **Lisinopril** are NOT prodrugs; they are active as administered. * **Advantage:** Prodrugs like **Valacyclovir** have much better oral absorption than their active counterpart (Acyclovir). * **Site of Activation:** Most prodrugs are activated in the liver, but **Sulfasalazine** is activated by bacteria in the colon into 5-ASA and Sulfapyridine.

Question 159: Which of the following factors has the maximum effect on the filtration of a drug by the glomerulus?

A. Lipid solubility
B. Plasma protein binding (Correct Answer)
C. Degree of ionization
D. Rate of tubular secretion

Explanation: **Explanation:** **Glomerular filtration** is a passive process where drugs are filtered through the capillary pores of the glomerulus [1]. The primary determinant of this process is the **molecular size** and the **free (unbound) fraction** of the drug [2]. 1. **Why Plasma Protein Binding is Correct:** Drugs in the plasma exist in two forms: bound to proteins (like albumin) and free. The glomerular filtration barrier acts as a sieve that prevents large molecules like plasma proteins from passing through [3]. Consequently, any drug molecule bound to a protein becomes too large to be filtered. Therefore, the **rate of filtration is directly proportional to the free fraction** of the drug [2]. High protein binding significantly limits glomerular filtration. 2. **Why Other Options are Incorrect:** * **Lipid Solubility & Degree of Ionization:** Unlike tubular reabsorption (which is highly dependent on lipid solubility and pH-dependent ionization), glomerular filtration is a bulk flow process through large pores [1]. It does not require the drug to cross lipid membranes; thus, lipid solubility and ionization have **no significant effect** on filtration. * **Rate of Tubular Secretion:** This is a separate process occurring in the renal tubules via active transporters (e.g., OAT, OCT). While it contributes to the total renal clearance, it does not influence the filtration occurring at the glomerulus [2]. **High-Yield Clinical Pearls for NEET-PG:** * **Glomerular Filtration Rate (GFR):** Only the **unbound** drug is filtered [2]. * **Tubular Secretion:** Can clear both **bound and unbound** drugs (e.g., Penicillin is highly protein-bound but rapidly cleared via secretion) [2]. * **Tubular Reabsorption:** Highly dependent on **Lipid solubility** and **pH** (Ion trapping). * **Formula:** Renal Clearance = (Filtration + Secretion) – Reabsorption.

Question 160: Which of the following drugs is metabolized through glycin(e) conjugation?

A. Benzodiazepines
B. Atzanavir
C. Ifosfamide
D. Nicotinic acid (Correct Answer)

Explanation: **Explanation:** **Correct Option: D (Nicotinic acid)** Metabolism occurs via two main phases: Phase I (Functionalization) and Phase II (Conjugation). **Glycine conjugation** is a specific Phase II pathway used for compounds containing a carboxylic acid group. **Nicotinic acid (Niacin)** and **Salicylates** (Aspirin) are the classic examples of drugs metabolized through this pathway. In this process, the drug is activated to a Coenzyme A thioester, which then reacts with glycine to form a water-soluble conjugate (e.g., nicotinuric acid) for renal excretion. **Analysis of Incorrect Options:** * **A. Benzodiazepines:** These drugs primarily undergo Phase I oxidation (via CYP3A4/2C19) followed by **Glucuronidation** (Phase II). Note: "LOT" drugs (Lorazepam, Oxazepam, Temazepam) undergo direct glucuronidation, bypassing Phase I. * **B. Atazanavir:** This protease inhibitor is extensively metabolized in the liver primarily by the **CYP3A4** isoenzyme (Phase I). * **C. Ifosfamide:** This alkylating agent is a prodrug that requires activation by **CYP3A4 and CYP2B6** (Phase I) to form its active metabolite, ifosfamide mustard. **High-Yield Clinical Pearls for NEET-PG:** * **Phase II Conjugation Mnemonic:** Remember **"S-G-A-G"** (Sulfation, Glucuronidation, Acetylation, Glycine conjugation). * **Glucuronidation** is the most common Phase II reaction. * **Acetylation** shows genetic polymorphism (Fast vs. Slow acetylators); drugs involved include **S**ulfonamides, **H**ydralazine, **I**soniazid, and **P**rocainamide (**SHIP**). * **Gray Baby Syndrome** occurs in neonates due to a deficiency of **UDP-glucuronyltransferase**, preventing the conjugation of Chloramphenicol.

Practice by Chapter

Absorption and Bioavailability

Practice Questions

Drug Distribution and Protein Binding

Practice Questions

Biotransformation and Metabolism Pathways

Practice Questions

Renal and Non-renal Excretion

Practice Questions

Compartment Models

Practice Questions

Dose-Response Relationships

Practice Questions

Drug Efficacy and Potency

Practice Questions

Drug Tolerance and Tachyphylaxis

Practice Questions

Population Pharmacokinetics

Practice Questions

Pharmacokinetic Variability

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free